← Leaderboards
Nina R Schooler
Long Island Jewish Medical Center
$2,212,512
Attributed
$2,212,512
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $160.2K · FY2009–10$200K$150K$100K$50K$0
'09
'10
Funding mix
By agency
NIH$2,212,512 · 3
By mechanism
R01$1,366,446 · 1
P30$525,636 · 1
U01$320,430 · 1
Top collaborators
No co-investigators on record.
Most similar at Long Island Jewish Medical Center
Same institution · by research overlap
- John M Kane$49,583,682
- Anil K Malhotra$14,850,627
- Delbert G Robinson$11,665,634
- Judith Jaeger$4,274,162
- Alan Mendelowitz$2,400,912
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsClinical ResearchSchizophreniaAntipsychotic AgentsMental Disorder ChemotherapyHuman Therapy EvaluationHuman SubjectQuality Of LifeMental Disorder DiagnosisLongitudinal Human StudyAntibioticsGlycineBehavioral /Social Science Research TagFunctional AbilityCognitionNeuropsychological TestsNeurotransmittersCognition DisordersNeuropharmacologyGlutamate ReceptorGenetic TechniquesDrug Screening /EvaluationGenetic MarkersHealth Science Research Support
Grant awards (9)
Relapse Prevention Study: Steering and Implementation$160,215
U01 · FY2010 · MH · contact PI
Relapse Prevention Study: Steering and Implementation$160,215
U01 · FY2009 · MH · contact PI
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$359,360
R01 · FY2003 · MH
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$349,312
R01 · FY2002 · MH
CORE--NOVEL INTERVENTION STRATEGIES IN SCHIZOPHRENIA$175,212
P30 · FY2002 · MH
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$339,543
R01 · FY2001 · MH
CORE--NOVEL INTERVENTION STRATEGIES IN SCHIZOPHRENIA$175,212
P30 · FY2001 · MH
TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENTS$318,231
R01 · FY2000 · MH
CORE--NOVEL INTERVENTION STRATEGIES IN SCHIZOPHRENIA$175,212
P30 · FY2000 · MH